Integral Health Asset Management’s Pfizer PFE Stock Holding History

Integral Health Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500,000	Closed	-$12.7M	–	99
2025 Q3	$12.7M	Sell	500,000 -200,000	-29%	-$4.94M	0.86%	36
2025 Q2	$17M	Buy	700,000 +400,000	+133%	+$9.33M	1.55%	24
2025 Q1	$7.6M	Buy	+300,000	New	+$7.85M	0.81%	36
2023 Q4	–	Sell	-150,000	Closed	-$4.98M	–	87
2023 Q3	$4.98M	Buy	+150,000	New	+$5.3M	0.69%	53
2022 Q2	–	Sell	-300,000	Closed	-$15.5M	–	80
2022 Q1	$15.5M	Buy	300,000 +100,000	+50%	+$5.19M	4.04%	3
2021 Q4	$11.8M	Sell	200,000 -50,000	-20%	-$2.48M	3.27%	8
2021 Q3	$10.8M	Buy	+250,000	New	+$11.1M	3.09%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Integral Health Asset Management's PFE Position: Q4 2025 in Review

Integral Health Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 500,000 shares — an estimated $12.7M sold.

Integral Health Asset Management first reported a position in PFE in Q3 2021 and held it in 7 quarters. The position peaked at $17M in Q2 2025. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Integral Health Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Integral Health Asset Management sold 500,000 Pfizer shares in Q4 2025, an estimated $12.7M.
Integral Health Asset Management first reported a position in Pfizer in Q3 2021 and held it in 7 quarters.
Integral Health Asset Management's Pfizer position peaked at $17M in Q2 2025.
2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.